Related references
Note: Only part of the references are listed.A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer
Bryan Oronsky et al.
MEDICAL ONCOLOGY (2017)
F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer
Benoit Thibault et al.
CANCER LETTERS (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.
Pierre Leblond et al.
INVESTIGATIONAL NEW DRUGS (2014)
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines
F. Mouawad et al.
ORAL ONCOLOGY (2014)
Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II
Caroline Ballot et al.
APOPTOSIS (2012)
Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II
Viviane Brel et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Interactions between the Etoposide Derivative F14512 and Human Type II Topoisomerases: Implications for the C4 Spermine Moiety in Promoting Enzyme-Mediated DNA Cleavage
Amanda C. Gentry et al.
BIOCHEMISTRY (2011)
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
Gordon John Sampson Rustin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system
Anna Kruczynski et al.
INVESTIGATIONAL NEW DRUGS (2011)
An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II
Sonia Chelouah et al.
PLOS ONE (2011)
F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System
Jean-Marc Barret et al.
CANCER RESEARCH (2008)
Share Paper
